5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.04%
Revenue growth of 4.04% while UPM.HE is flat. Bruce Berkowitz would check if a small edge can widen further.
-8.38%
Negative gross profit growth while UPM.HE is at 5.53%. Joel Greenblatt would examine cost competitiveness or demand decline.
-22.90%
Negative EBIT growth while UPM.HE is at 38.93%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-22.90%
Negative operating income growth while UPM.HE is at 38.93%. Joel Greenblatt would press for urgent turnaround measures.
-19.83%
Negative net income growth while UPM.HE stands at 36.04%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.67%
Negative EPS growth while UPM.HE is at 35.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-16.67%
Negative diluted EPS growth while UPM.HE is at 35.14%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-3.79%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-3.79%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
401.80%
OCF growth above 1.5x UPM.HE's 16.59%. David Dodd would confirm a clear edge in underlying cash generation.
168.23%
FCF growth above 1.5x UPM.HE's 19.47%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-39.39%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-42.40%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-15.23%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-14.87%
Negative 10Y OCF/share CAGR while UPM.HE stands at 36.10%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
200.18%
5Y OCF/share CAGR above 1.5x UPM.HE's 74.91%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
645.27%
3Y OCF/share CAGR above 1.5x UPM.HE's 75.17%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
120.83%
Net income/share CAGR above 1.5x UPM.HE's 77.44% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
145.45%
Below 50% of UPM.HE's 342.22%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
150.00%
3Y net income/share CAGR above 1.5x UPM.HE's 92.28%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-12.34%
Negative 5Y equity/share growth while UPM.HE is at 7.20%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
17.76%
3Y equity/share CAGR above 1.5x UPM.HE's 5.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.96%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.28%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.41%
Negative asset growth while UPM.HE invests at 0.83%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.38%
BV/share growth above 1.5x UPM.HE's 2.71%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.32%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.34%
SG&A growth of 1.34% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.